"This book explores the relationship between the gut microbiome and cancer, illuminating various facets from fundamental roles to personalized therapies. It provides a comprehensive overview of the impact of the gut microbiome on cancer development, offering potential for innovative diagnostic and treatment approaches"--
This book explores the relationship between the gut microbiome and cancer, illuminating various facets from fundamental roles to personalized therapies. It provides a comprehensive overview of the impact of the gut microbiome on cancer development, offering potential for innovative diagnostic and treatment approaches.
- The book discusses the role of dysbiosis in cancer development, the influence of the microbiome on treatment responses, and strategies to modulate the microbiome for enhanced therapies.
- It reviews the influence of the gut microbiome on immunotherapy resistance and chemoresistance in cancer patients.
- Additionally, the book presents gut microbiome biomarkers for cancer diagnosis and prognosis, the implication of the gut-brain axis on cancer development and progression, and the impact of diet and lifestyle on the microbiome.
Towards the end, the book investigates the role of the gut microbiome in pediatric cancer and provides an outlook on the future challenges, technological advancements, and ethical considerations of gut microbiome research in the context of personalized cancer therapies. This book is intended for cancer researchers, medical oncologists, clinicians, pharmacologists, translational investigators, and medical students.
This book explores the role of the gut microbiome in cancer initiation, progression, and treatment response to present gut microbiome biomarkers for cancer diagnosis and strategies for modulating microbiome for personalized cancer therapies. The work is intended for cancer researchers, medical oncologists, clinicians, and pharmacologists.
Chapter
1. Introduction to the Gut Microbiome and Cancer.
Chapter
2. Gut Microbiome Dysbiosis and Cancer Risk.
Chapter
3. Gut Microbiome and Cancer Treatment Response.
Chapter
4. Gut Microbiome Modulation for Personalized Cancer Therapies.
Chapter
5. Gut Microbiome and Immunotherapy Resistance.
Chapter
6. Gut Microbiome and Chemotherapy Resistance.
Chapter
7. Gut Microbiome Biomarkers for Cancer Diagnosis and Prognosis.
Chapter
8. Microbial Metabolites and Cancer.
Chapter
9. Gut-Brain Axis and Cancer Delving into the intricate connection between the gut and the brain.
Chapter
10. Gut Microbiome and Cancer-Related Inflammation.
Chapter
11. Diet, Lifestyle, and the Gut Microbiome.
Chapter
12. Gut Microbiome and Pediatric Cancer.
Chapter
13. Gut Microbiome and Systemic Side Effects of Cancer Therapies.
Chapter
14. Gut Microbiome and Precision Medicine in Cancer.
Chapter
15. Therapeutic Potential of the Gut Virome in Cancer.
Chapter
16. Microbiome-Based Cancer Therapeutics.
Chapter
17. Gut Microbiome Engineering for Cancer Therapies.
Chapter
18. Future Perspectives and Challenges in Gut Microbiome Research.
Zodwa Dlamini is a Professor of Molecular Oncology and known for her unwavering commitment to advancing precision oncology. At the core of her career is her pivotal role as the Founding Director of the Pan African Cancer Research Institute (PACRI). Additionally, as the Director of the SAMRC Precision Oncology Research Unit (PORU) and a DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), she is fully committed to advancing precision medicine in the battle against cancer. Beyond her institutional leadership, Professor Dlamini also serves as a distinguished member of the American Association for Cancer Research (AACR) Regional Advisory Committee on Sub-Saharan Africa. She additionally guides the AACR Pathology Resources in Africa Advisory Group, actively identifying strategies to address gaps in cancer pathology services across the African continent. Professor Dlamini extends her contributions to the African Organisation for Research and Training in Cancer (AORTIC), where she actively influences the organization's strategic direction and mission as a member of the Research Committee Scientific Advisory Board. Her dedication to advancing cancer research in Africa was honoured with a Special Award from the Council and Executive of the African Society of Morphology and she was then admitted as an "Honorary Fellow" of the West African College of Morphologists. Moreover, she is an Overseas Fellow of the Royal Society of Medicine (London), Professional Member of the New York Academy of Sciences (USA) and a member of the Academy of Science of South Africa, highlighting her contributions to the field of Science. Through her multifaceted efforts, Professor Zodwa Dlamini remains steadfast in her commitment to shaping the ever-evolving landscape of cancer research and her journey is driven by an unshakable belief that cancer can be conquered, paving the way for a healthier and more equitable world.
